期刊文献+

NT-proBNP与急诊PCI术中无复流的相关性研究 被引量:2

The Correlation between NT-proBNP and No-reflow in Patients Undergoing Emergent Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:研究血浆N末端脑钠肽原(NT-proBNP)与急诊经皮冠状动脉介入治疗(PCI)术中无复流现象的相关性。方法:选择2014年1月-2015年12月笔者所在医院急救中心住院治疗的急性心肌梗死患者200例,年龄40~78岁,符合纳入条件者共132例,平均年龄63.7岁。所有患者术前均服用阿司匹林、氯吡咯雷负荷量。均在症状发生12 h内行PCI,处理血管均无残余狭窄。冠脉造影术前抽取静脉血,立即行NTproBNP、白介素(IL-6)数值检测。根据冠脉造影术中TIMI血流分级分为无复流组和血流正常组,术后TIMI血流0~2级患者为无复流组,TIMI血流3级患者为血流正常组。比较两组间术前NT-proBNP、IL-6数值有无统计学差异。用Logistic回归分析评价NT-proBNP对记性心肌梗死(AMI)患者急诊PCI术中无复流的预测价值。结果:无复流组NT-proBNP水平明显高于血流正常组(P<0.01)。无复流组IL-6明显高于血流正常组(P<0.01)。入院NT-proBNP>1247.50 ng/L是急性心肌梗死患者急诊PCI术中无复流的独立危险因素,其敏感性90.0%,特异性79.5%。结论:急性心肌梗死患者急诊PCI术中无复流发生率与NT-proBNP、IL-6水平呈正相关。 Objective: To study the correlation between NT-proBNP and the no-reflow phenomenon in the emergency percutaneous coronary intervention(PCI).Method: NT-proBNP and IL-6 were obtained from 200 hospitalized patients with acute myocardial infarction from January 2014 to December 2015 in our emergency center, age between 40 and 78 years old.A total of 132 patients met the inclusion conditions with an average age of 63.7 years.All patients took Aspirin and Clopidogrel loading dose before treatment, and adept PCI within 12 hours occuring acute myocardial infarction(AMI) symptoms, with the coronary arteries no residual stenosis after PCI.Took 2 ml venous blood before PCI and detected NT-proBNP, interleukin-6(IL-6) immediately.According to coronary angiography TIMI flow classification the patients were divided into no-reflow group and normal blood flow group, patients with postoperative TIMI flow 0-2 levels as no-reflow group, TIMI flow grade 3 patients as normal blood flow group.The differences between the two groups of NT-proBNP, IL-6 were compared using t-test.To evaluate the predictive value of NT-proBNP in no-reflow phenomenon within emergency PCI using Logistic regression analysis.Result: The NT-proBNP level of no-reflow group was obviously higher than that of normal blood flow group(P〈0.01).The IL-6 level of no-reflow group was obviously higher than that of normal blood flow group(P〈0.01).NT-proBNP〉1247.50ng/Lwastheindependentriskfactorforno-reflowinthepatientswithAMIinemergencyPCI, with the sensitivity 90.0% , specificity of 79.5%.Conclusion: No-reflow is positively correlated with NT-proBNP level and IL-6 level in the emergency PCI in patients with AMI.
出处 《中外医学研究》 2017年第5期7-9,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 NT-PROBNP 无复流 IL-6 NT-proBNP No-reflow IL-6
  • 相关文献

参考文献4

二级参考文献24

  • 1赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 2杨新春 王乐丰 佟子川 等.急性心肌梗死症状发作-首次球囊扩张时间和症状发作--进入导管室时间与左心室射血分数和肌酸激酶MB同工酶的关系[J].中国循环杂志,2002,17:77-77.
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4陆再英.钟南山.内科学.第7版.北京:人民卫生出版社,2007.794.
  • 5Birukova AA,Xing J, Fu P, et al. Atrial natriuretic peptide at- tenuates LPS-induced lung vascular leak: role of PAK1. Am J Physiol Lung Cell Mol Physiol,2010,299 :652-663.
  • 6Omland T,de Lemos JA. Amino-terminal pro-B-type natriuret ic peptides in stable and unstable ischemic heart disease. Am J Cardiol,2008,101:61-66.
  • 7Wolber T, Maeder M, Richli H, et al. N-terminal pro-brain natriuretic peptide used for prediction of coronary artery steno- sis. Eur J Clin Invest,2007,37:18-25.
  • 8Aylin Y, Sadik A, Cagatay E, et al. Effects of lesion complexity on haseLifie and postproeedural B-type natrluretic peptide levels in patients undergoing percutaneous coronary interventions. Tex Heart Inst J,2007,34:282-289.
  • 9苏华,周胜华,潘宏伟,等.脑钠肽对不稳定型心绞痛和(或)1FST段抬高心肌梗死患者冠状动脉病变程度的预测.临床心魄管病杂志,2008,24:117-119.
  • 10Srikanth S, Ambrose lA. Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI [J] . Curr Cardiol Rev,2012,8(3) :168 -176.

共引文献2019

同被引文献33

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部